SHA:603233 Market Cap

SHA:603233 has a market cap or net worth of 22.57 billion as of March 6, 2026. Its market cap has increased by 40.17% in one year.

Market Cap

22.57B

Enterprise Value

23.16B

Revenue

26.83B

Ranking

n/a

PE Ratio

19.59

Stock Price

19.82

Market Cap Chart

Since July 31, 2017, SHA:603233's market cap has increased from 14.24B to 22.57B, an increase of 58.51%. That is a compound annual growth rate of 5.50%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	22.57B	12.49%
Dec 31, 2025	20.07B	17.00%
Dec 31, 2024	17.15B	-39.52%
Dec 29, 2023	28.36B	-24.55%
Dec 30, 2022	37.59B	12.85%
Dec 31, 2021	33.31B	-35.46%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Jul 31, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Asymchem Laboratories (Tianjin)	34.32B
Beijing Tiantan Biological Products	30.93B
Xiamen Amoytop Biotech	28.94B
Hualan Biological Engineering	27.47B
Yili Chuanning Biotechnology	24.37B
Suzhou Zelgen Biopharmaceuticals	20.57B
BrightGene Bio-Medical Technology	17.37B
Sinocelltech Group	16.52B

Market Cap Rankings